2023 | Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the Phase 3 POLARIX trial | Song, Yuqin; Tilly, Herve; Rai, Shinya; Zhang, Huilai; Jin, Jie; Goto, Hideki; Terui, Yasuhito; Shin, Ho-Jin; Kim, Won Seog S; Cao, Junning; Feng, Jifeng; Eom, Hyeon-Seok; Kim, Tae Min; CHENG-HONG TSAI ; Gau, Jyh-Pyng; Koh, Hideo; Zhang, Liling; Song, Yongping; Yang, Yu; Li, Wei; Huang, He; Ando, Kiyoshi; Sharman, Jeff P; Sehn, Laurie H; Bu, Lilian; Wang, Xin; Jiang, Yanwen; Hirata, Jamie; Lee, Calvin; Zhu, Jun; Izutsu, Koji | Blood | 5 | 5 | |